Developing a Flexible National Wastewater Surveillance System for COVID-19 and Beyond

被引:47
|
作者
Keshaviah, Aparna [1 ]
Hu, Xindi C. [1 ]
Henry, Marisa [1 ]
机构
[1] Math, Princeton, NJ USA
基金
美国国家卫生研究院;
关键词
D O I
10.1289/EHP8572
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
BACKGROUND: Wastewater testing offers a cost-effective strategy for measuring population disease prevalence and health behaviors. For COVID-19, wastewater surveillance addresses testing gaps and provides an early warning for outbreaks. As U.S. federal agencies build a National Wastewater Surveillance System around the pandemic, thinking through ways to develop flexible frameworks for wastewater sampling, testing, and reporting can avoid unnecessary system overhauls for future infectious disease, chronic disease, and drug epidemics. OBJECTIVES: We discuss ways to transform a historically academic exercise into a tool for epidemic response. We generalize lessons learned by a global network of wastewater researchers around validation and implementation for COVID-19 and opioids while also drawing on our experience with wastewater-based epidemiology in the United States. DISCUSSION: Sustainable wastewater surveillance requires coordination between health and safety officials, utilities, labs, and researchers. Adapting sampling frequency, type, and location to threat level, community vulnerability, biomarker properties, and decisions that wastewater data will inform can increase the practical value of the data. Marketplace instabilities, coupled with a fragmented testing landscape due to specialization, may require officials to engage multiple labs to test for known and unknown threats. Government funding can stabilize the market, balancing commercial pressures with public good, and incentivize data sharing. When reporting results, standardizing metrics and contextualizing wastewater data with health resource data can provide insights into a community's vulnerability and identify strategies to prevent health care systems from being overwhelmed. If wastewater data will inform policy decisions for an entire community, comparing characteristics of the wastewater treatment plant's service population to those of the larger community can help determine whether the wastewater data are generalizable. Ethical protocols may be needed to protect privacy and avoid stigmatization. With data-driven approaches to sample collection, analysis, and interpretation, officials can use wastewater surveillance for adaptive resource allocation, pandemic management, and program evaluation.
引用
收藏
页数:8
相关论文
共 50 条
  • [41] COVID-19 and beyond
    Haddad, F. S.
    BONE & JOINT JOURNAL, 2020, 102B (06): : 653 - 654
  • [42] COVID-19 and Beyond
    van Weeghel, Stef
    INTERTAX, 2020, 48 (8-9): : 733 - 735
  • [43] COVID-19 and Beyond
    Dolch, Norman A.
    JOURNAL OF NONPROFIT EDUCATION AND LEADERSHIP, 2020, 10 (03) : VII - VIII
  • [44] Big data in COVID-19 surveillance system: A commentary
    Jahanbakhsh, Maryam
    Ashrafi-Rizi, Hasan
    Jangi, Majid
    Sattari, Mohammad
    JOURNAL OF EDUCATION AND HEALTH PROMOTION, 2020, 9 (01)
  • [45] Epidemiological surveillance in COVID-19 pandemic: EPIVIGILA system
    Taramasco, Carla
    Rimassa, Carla
    Romo, Johana Acevedo
    Zavando, Adolfo Cesped
    Bravo, Rodrigo Fuentes
    MEDWAVE, 2022, 22 (05):
  • [46] Wastewater Surveillance Can Function as an Early Warning System for COVID-19 in Low-Incidence Settings
    Assoum, Mohamad
    Lau, Colleen L.
    Thai, Phong K.
    Ahmed, Warish
    Mueller, Jochen F.
    Thomas, Kevin V.
    Choi, Phil Min
    Jackson, Greg
    Selvey, Linda A.
    TROPICAL MEDICINE AND INFECTIOUS DISEASE, 2023, 8 (04)
  • [47] COVID-19 and Nanoscience in the Developing World: Rapid Detection and Remediation in Wastewater
    Adeel, Muhammad
    Farooq, Tahir
    Shakoor, Noman
    Ahmar, Sunny
    Fiaz, Sajid
    White, Jason C.
    Gardea-Torresdey, Jorge L.
    Mora-Poblete, Freddy
    Rui, Yukui
    NANOMATERIALS, 2021, 11 (04)
  • [48] COVID-19 and the Gastrointestinal System: Lesions Beyond the Symptoms?
    Grande, Giuseppe
    Cocca, Silvia
    Russo, Salvatore
    Mangiafico, Santi
    Caruso, Angelo
    Pigo, Flavia
    Conigliaro, Rita
    Bertani, Helga
    ACG CASE REPORTS JOURNAL, 2020, 7 (09)
  • [49] National active surveillance to understand and inform neonatal care in COVID-19
    Gale, Chris
    Knight, Marian
    Ladhani, Shamez
    Draper, Elizabeth S.
    Sharkey, Don
    Doherty, Cora
    Mactier, Helen
    Kurinczuk, Jennifer J.
    ARCHIVES OF DISEASE IN CHILDHOOD-FETAL AND NEONATAL EDITION, 2020, 105 (04): : F346 - F347
  • [50] Safety surveillance for COVID-19 vaccines at the national pharmacovigilance center lareb
    Van Hunsel, Florence
    Oosterhuis, Ingrid
    Scholl, Joep
    Van Puijenbroek, Eugene
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2022, 31 : 228 - 229